Aras Cengiz, Senturk Fevzi, Koytak Arif, Dogramaci Mahmut, Erdur Sevil Karaman, Kocabora Selim
Department of Ophthalmology, Istanbul Medipol Medical School, Istanbul, Turkey.
Department of Ophthalmology, Medical Faculty, Bezmialem Vakif University, Istanbul, Turkey.
Int J Retina Vitreous. 2022 Jun 11;8(1):36. doi: 10.1186/s40942-022-00391-3.
Autologous plasmin enzyme facilitates the induction of posterior vitreous detachment(PVD) during vitrectomy in young patients. We proposed the concept of in-vivo generated plasmin which is based on the injection of tissue plasminogen activator(t-PA) and autologous whole blood(AWB) into the vitreous cavity. The purpose of this pilot study is to report the efficacy of preoperative simultaneous intravitreal injection of(t-PA) and autologous whole blood in facilitating the intraoperative induction of PVD in young patients with various vitreoretinal pathologies.
Seventeen eyes of 16 young patients with various vitreoretinal pathologies requiring vitrectomy, who received simultaneous intravitreal injection of 0.1 ml of AWB and 25 µg of t-PA, 3 days prior to surgery were retrospectively reviewed. Outcome measures were the number of attempts required to achieve successful intraoperative separation of the posterior hyaloid; the postoperative visual acuity; and intraoperative and postoperative complications.
The mean age of the patients was 23.87 ± 10.09 years, ranging from 10 to 39 years. Eight of 16 patients were men. The mean follow-up time was 19.35 ± 5.04 months, ranging from 12 to 26 months. Surgical indications for vitrectomy were chronic retinal detachment (n = 7), traumatic retinal detachment without proliferative vitreoretinopathy(n = 3), traumatic macular hole(n = 1), secondary vasoproliferative tumor(n = 4) and optic pit maculopathy(n = 2). Patients with retinal detachment complicated with PVR and those who were older than 40 years of age were excluded from the study. Separation of the Weiss ring from the optic nerve head was achieved intraoperatively in all cases, with a mean number of 2.86 ± 1.4 attempts. While the mean preoperative LogMAR visual acuity was 1.38 ± 0.59, ranging from 2.40 to 0.50, it was a mean of 0.51 ± 0.29, ranging from 1.00 to 0.10 at final postoperative exam(p < 0.001; paired samples t-test). No preoperative or intraoperative complications were noted.
Preoperative simultaneous intravitreal injection of 25 µg t-PA with 0.1 ml of AWB facilitates the intraoperative induction of posterior vitreous detachment in young patients.
自体纤溶酶在年轻患者玻璃体切除术中有助于诱导玻璃体后脱离(PVD)。我们提出了体内生成纤溶酶的概念,该概念基于向玻璃体腔注射组织纤溶酶原激活剂(t-PA)和自体全血(AWB)。本初步研究的目的是报告术前玻璃体腔内同时注射t-PA和自体全血对患有各种玻璃体视网膜病变的年轻患者术中诱导PVD的疗效。
回顾性分析16例患有各种需要玻璃体切除术的玻璃体视网膜病变的年轻患者的17只眼,这些患者在手术前3天接受了0.1 ml AWB和25 μg t-PA的玻璃体腔内同时注射。观察指标为术中成功分离后玻璃体膜所需的尝试次数、术后视力以及术中和术后并发症。
患者的平均年龄为23.87±10.09岁,范围为10至39岁。16例患者中有8例为男性。平均随访时间为19.35±5.04个月,范围为12至26个月。玻璃体切除术的手术指征为慢性视网膜脱离(n = 7)、无增殖性玻璃体视网膜病变的外伤性视网膜脱离(n = 3)、外伤性黄斑裂孔(n = 1)、继发性血管增生性肿瘤(n = 4)和视盘黄斑病变(n = 2)。视网膜脱离合并增殖性玻璃体视网膜病变的患者以及年龄大于40岁的患者被排除在研究之外。所有病例术中均实现了Weiss环与视神经乳头的分离,平均尝试次数为2.86±1.4次。术前平均LogMAR视力为1.38±0.59,范围为2.40至0.50,术后最终检查时平均为0.51±0.29,范围为1.00至0.10(p < 0.001;配对样本t检验)。未观察到术前或术中并发症。
术前玻璃体腔内同时注射25 μg t-PA和0.1 ml AWB有助于年轻患者术中诱导玻璃体后脱离。